Maytansine as a cause of acute proliferative disorder of bladder urethelium in the rat

Ralph W deVere White, M. O'Brien, J. Krikorian, R. Babayan, C. A. Olsson

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Male Wistar Lewis rats were injected with maytansine at a total dose of 0.425 to 0.6 mg/kg over a 3-week period. Biopsies taken at 5 weeks showed that 23% of the bladders had hyperplasia or other abnormalities. Of the bladder biopsies done for the first time at 8 weeks, 80% demonstrated papillary hyperplasia. A small number of biopsies at 13 and 19 weeks still showed hyperplasia and minimal inflammatory reaction. These results were seen regardless of prior biopsy, the presence of bladder calculi, and/or the dose level used. It is not clear from the data whether the observed changes are reversible or precarcinogenic. However, these changes closely resembled the histologic features described in the evolution of bladder cancer in rats fed N-C4-(5-nitro-2-furyl)-2-thiazolyl formamide.

Original languageEnglish (US)
Pages (from-to)183-184
Number of pages2
JournalCancer Treatment Reports
Volume67
Issue number2
StatePublished - 1983
Externally publishedYes

Fingerprint

Maytansine
Urinary Bladder
Hyperplasia
Biopsy
Urinary Bladder Calculi
Urinary Bladder Neoplasms
Wistar Rats

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

deVere White, R. W., O'Brien, M., Krikorian, J., Babayan, R., & Olsson, C. A. (1983). Maytansine as a cause of acute proliferative disorder of bladder urethelium in the rat. Cancer Treatment Reports, 67(2), 183-184.

Maytansine as a cause of acute proliferative disorder of bladder urethelium in the rat. / deVere White, Ralph W; O'Brien, M.; Krikorian, J.; Babayan, R.; Olsson, C. A.

In: Cancer Treatment Reports, Vol. 67, No. 2, 1983, p. 183-184.

Research output: Contribution to journalArticle

deVere White, RW, O'Brien, M, Krikorian, J, Babayan, R & Olsson, CA 1983, 'Maytansine as a cause of acute proliferative disorder of bladder urethelium in the rat', Cancer Treatment Reports, vol. 67, no. 2, pp. 183-184.
deVere White, Ralph W ; O'Brien, M. ; Krikorian, J. ; Babayan, R. ; Olsson, C. A. / Maytansine as a cause of acute proliferative disorder of bladder urethelium in the rat. In: Cancer Treatment Reports. 1983 ; Vol. 67, No. 2. pp. 183-184.
@article{7d6619c825f84395a604afb52fca7e00,
title = "Maytansine as a cause of acute proliferative disorder of bladder urethelium in the rat",
abstract = "Male Wistar Lewis rats were injected with maytansine at a total dose of 0.425 to 0.6 mg/kg over a 3-week period. Biopsies taken at 5 weeks showed that 23{\%} of the bladders had hyperplasia or other abnormalities. Of the bladder biopsies done for the first time at 8 weeks, 80{\%} demonstrated papillary hyperplasia. A small number of biopsies at 13 and 19 weeks still showed hyperplasia and minimal inflammatory reaction. These results were seen regardless of prior biopsy, the presence of bladder calculi, and/or the dose level used. It is not clear from the data whether the observed changes are reversible or precarcinogenic. However, these changes closely resembled the histologic features described in the evolution of bladder cancer in rats fed N-C4-(5-nitro-2-furyl)-2-thiazolyl formamide.",
author = "{deVere White}, {Ralph W} and M. O'Brien and J. Krikorian and R. Babayan and Olsson, {C. A.}",
year = "1983",
language = "English (US)",
volume = "67",
pages = "183--184",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Maytansine as a cause of acute proliferative disorder of bladder urethelium in the rat

AU - deVere White, Ralph W

AU - O'Brien, M.

AU - Krikorian, J.

AU - Babayan, R.

AU - Olsson, C. A.

PY - 1983

Y1 - 1983

N2 - Male Wistar Lewis rats were injected with maytansine at a total dose of 0.425 to 0.6 mg/kg over a 3-week period. Biopsies taken at 5 weeks showed that 23% of the bladders had hyperplasia or other abnormalities. Of the bladder biopsies done for the first time at 8 weeks, 80% demonstrated papillary hyperplasia. A small number of biopsies at 13 and 19 weeks still showed hyperplasia and minimal inflammatory reaction. These results were seen regardless of prior biopsy, the presence of bladder calculi, and/or the dose level used. It is not clear from the data whether the observed changes are reversible or precarcinogenic. However, these changes closely resembled the histologic features described in the evolution of bladder cancer in rats fed N-C4-(5-nitro-2-furyl)-2-thiazolyl formamide.

AB - Male Wistar Lewis rats were injected with maytansine at a total dose of 0.425 to 0.6 mg/kg over a 3-week period. Biopsies taken at 5 weeks showed that 23% of the bladders had hyperplasia or other abnormalities. Of the bladder biopsies done for the first time at 8 weeks, 80% demonstrated papillary hyperplasia. A small number of biopsies at 13 and 19 weeks still showed hyperplasia and minimal inflammatory reaction. These results were seen regardless of prior biopsy, the presence of bladder calculi, and/or the dose level used. It is not clear from the data whether the observed changes are reversible or precarcinogenic. However, these changes closely resembled the histologic features described in the evolution of bladder cancer in rats fed N-C4-(5-nitro-2-furyl)-2-thiazolyl formamide.

UR - http://www.scopus.com/inward/record.url?scp=0020596787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020596787&partnerID=8YFLogxK

M3 - Article

C2 - 6825127

AN - SCOPUS:0020596787

VL - 67

SP - 183

EP - 184

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 2

ER -